IMACTIS SAS 20 Rue du Tour de l’Eau
38400 Saint Martin d’Hères, France
Tel : +334 5800 5580
IMACTIS Inc. (U.S. inquiries only) 185 Alewife Brook Parkway
Suite 210
Cambridge, MA 02138, USA
Tel : (631) 693-6041
Email :
♦ Review of the system: description, intended use, procedure details, main benefits and clinical data
♦ CT-Navigation could be considered as a first option in the diagnosis and/or treatment of lesions in difficult locations, even if further studies are necessary
J. A. Gómez Patiño, S. Méndez Alonso, M. Alfageme, R. González Costero, A. García Suárez, J. González Plaza, V. Perdomo Suriel, M. L. Collado Torres – ECR 2020
♦ Case review of seven patients: 4 biopsies (hepatic, pulmonary, retroperitoneal and osseous lesions) and 3 ablations (pulmonary, pancreatic and hepatic carcinomas)
♦ The system was easily operated, facilitated pre-procedure planing and displayed an accurate needle trajectory
♦ Benefits for ablations (higher accuracy, better targeting of small lesions) and biopsies (fewer CT controls) without significant post-procedure complications
Yadiel Sánchez, BA, Dmitry S. Trifanov, MD, Taj M. Kattapuram, MD, Haiyang Tao, MD, PhD, Anand M. Prabhakar, MD, MBA, Ronald S. Arellano, MD, Raul N. Uppot, MD – Journal of the American College of Radiology
♦ Prospective controlled multicenter study protocol (500 patients maximum)
♦ The aim is to assess the safety, efficacy and performance within the 2 patient groups
RC. Rouchy, A. Moreau-Gaudry, E. Chipon, S. Aubry, L. Pazart, B. Lapuyade, M. Durand, M. Hajjam, S. Pottier, B. Renard, R. Logier, X. Orry, A. Cherifi, E. Quehen, G. Kervio, O. Favelle, F. Patat, E. De Kerviler, C. Hughes, M. Medici, J. Ghelfi, A. Mounier & I. Bricault – Trials
♦ Prospective controlled study involving 120 patients
♦ Accuracy improved by a factor of 2 (when using the navigation system)
♦ Fewer acquisition scans: 2 vs 3 (when using the navigation system)